Silo Pharma【SILO】株式ニュース

名称	銘柄コード	市場	種別
Silo Pharma Inc	SILO	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.09	-7.44%	1.12	13:00:10

始値	安値	高値	終値	前日終値
1.26	1.06	1.26	1.10	1.21

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/14	06:08	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/6/14	02:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/12	05:00	EDGAR2	Form D - Notice of Exempt Offering of Securities
2024/6/07	21:18	GLOBE	Silo Pharma Announces Successful Production of its SP-26..
2024/6/07	05:52	EDGAR2	Form 8-K - Current report
2024/6/07	05:50	GLOBE	Silo Pharma Announces Closing of $2 Million Registered..
2024/6/06	19:07	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/6/05	21:00	GLOBE	Silo Pharma Announces $2 Million Registered Direct Offering..
2024/6/05	05:05	EDGAR2	Form 8-K - Current report
2024/6/04	21:41	GLOBE	Silo Pharma Submits Pre-Investigational New Drug Application..
2024/5/21	21:45	GLOBE	Silo Pharma Announces Positive Results from Study for..
2024/5/14	21:45	GLOBE	Silo Pharma to Participate in FDA Meeting Exploring Emerging..
2024/5/14	05:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/4/23	21:15	GLOBE	Silo Pharma Announces Positive Results for Intranasal PTSD..
2024/4/10	21:11	GLOBE	Silo Pharma set to Acquire Exclusive Licensing for Promising..
2024/3/20	21:30	GLOBE	Silo Pharma Exercises Option for Exclusive License Agreement..
2024/3/18	20:15	GLOBE	Silo Pharma Files Patent for Groundbreaking Ketamine Implant..
2024/2/28	22:25	GLOBE	Silo Pharma Completes Successful Dose-Ranging Study of..
2024/2/14	22:45	GLOBE	Silo Pharma’s SP-26 Ketamine Implant Demonstrates Successful..
2024/2/02	03:15	EDGAR2	Form 8-K - Current report
2024/2/02	00:00	GLOBE	Silo Pharma Announces Pipeline Prioritization for 2024..
2024/1/26	07:29	EDGAR2	Form S-3/A - Registration statement under Securities Act of..
2024/1/26	07:27	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/24	22:55	GLOBE	Silo Pharma Announces Positive Results in Alzheimer’s..
2024/1/24	07:01	EDGAR2	Form S-3 - Registration statement under Securities Act of..
2024/1/12	02:15	EDGAR2	Form 8-K/A - Current report: [Amend]
2024/1/10	06:30	EDGAR2	Form 8-K - Current report
2024/1/04	22:55	GLOBE	Silo Pharma Successfully Completes First Phase of..
2023/12/28	22:25	GLOBE	Silo Pharma and Partner Receive Regulatory Approval to Begin..
2023/12/22	06:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/21	06:58	EDGAR2	Form 8-K12B - Notification that a class of securities of..
2023/12/19	09:44	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/12	06:05	EDGAR2	Form 8-K - Current report
2023/12/08	08:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/06	06:05	EDGAR2	Form 8-K - Current report
2023/12/05	06:55	EDGAR2	Form 8-K - Current report
2023/12/01	11:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/28	07:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/23	06:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/21	22:01	GLOBE	Silo Pharma Enters into Exclusive License Agreement with..
2023/11/21	09:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/14	07:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08	22:11	GLOBE	Silo Pharma to Initiate Dose-Ranging Study of Novel..
2023/10/24	06:01	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
2023/10/24	06:00	EDGAR2	Form DEF 14A - Other definitive proxy statements
2023/10/16	21:11	GLOBE	Silo Pharma’s SPU-21 Peptide Shows Positive Results Against..
2023/10/11	21:35	GLOBE	Silo Pharma Initiates Human Factor Study of SPC-15 for the..
2023/10/11	05:00	EDGAR2	Form PRE 14A - Other preliminary proxy statements
2023/9/20	21:28	GLOBE	Silo Pharma Announces Positive Data on SPC-15 for PTSD and..
2023/9/12	21:50	GLOBE	Silo Pharma Initiates Feasibility Study of SPC-15 Novel..